Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Unlike GLP-1 agonists, it preserves lean muscle mass during caloric restriction
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has demonstrated significant weight loss benefits in clinical trials, with participants losing up to 15% of body weight over 68 weeks
Diabetes (2015) 64(7):251325
Results vary, but some patients begin noticing changes within 58 weeks
US$ 24.12
US$ 26.26
US$ 22.93
US$ 2249.50
Sold : Login>>
